Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 21 | 2021 | 364 | 4.280 |
Why?
|
| Caenorhabditis elegans Proteins | 15 | 2021 | 367 | 3.440 |
Why?
|
| RNA | 11 | 2020 | 360 | 2.370 |
Why?
|
| Caenorhabditis elegans | 15 | 2021 | 563 | 2.280 |
Why?
|
| 3' Untranslated Regions | 8 | 2021 | 87 | 1.690 |
Why?
|
| Gene Expression Regulation, Developmental | 10 | 2021 | 587 | 1.310 |
Why?
|
| Embryonic Development | 4 | 2021 | 123 | 1.280 |
Why?
|
| Gene Expression Regulation | 8 | 2014 | 1498 | 1.250 |
Why?
|
| Carrier Proteins | 5 | 2017 | 661 | 1.140 |
Why?
|
| RNA, Messenger | 10 | 2021 | 1388 | 1.130 |
Why?
|
| RNA, Catalytic | 6 | 2002 | 18 | 0.920 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 2 | 2013 | 10 | 0.910 |
Why?
|
| RNA, Helminth | 3 | 2015 | 44 | 0.870 |
Why?
|
| Oogenesis | 4 | 2013 | 38 | 0.770 |
Why?
|
| Nucleic Acid Conformation | 7 | 2013 | 223 | 0.700 |
Why?
|
| Proteins | 5 | 2017 | 707 | 0.690 |
Why?
|
| Animals | 30 | 2021 | 17734 | 0.680 |
Why?
|
| Binding Sites | 10 | 2015 | 821 | 0.640 |
Why?
|
| Electrophoretic Mobility Shift Assay | 5 | 2010 | 60 | 0.630 |
Why?
|
| Protein Binding | 12 | 2020 | 1475 | 0.620 |
Why?
|
| Conserved Sequence | 2 | 2014 | 169 | 0.620 |
Why?
|
| Alternative Splicing | 3 | 2013 | 116 | 0.610 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 2013 | 10 | 0.600 |
Why?
|
| Base Sequence | 11 | 2014 | 1253 | 0.570 |
Why?
|
| RNA Stability | 2 | 2013 | 86 | 0.570 |
Why?
|
| Stem Cells | 2 | 2014 | 239 | 0.540 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 390 | 0.540 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 42 | 0.530 |
Why?
|
| Oleic Acid | 1 | 2014 | 21 | 0.530 |
Why?
|
| Protein Biosynthesis | 3 | 2013 | 280 | 0.530 |
Why?
|
| Cell Differentiation | 5 | 2015 | 1233 | 0.510 |
Why?
|
| Publishing | 1 | 2015 | 83 | 0.510 |
Why?
|
| Oligodendroglia | 2 | 2011 | 26 | 0.500 |
Why?
|
| RNA, Messenger, Stored | 2 | 2016 | 5 | 0.500 |
Why?
|
| Adenosine | 3 | 2003 | 70 | 0.490 |
Why?
|
| RNA Editing | 1 | 2013 | 26 | 0.480 |
Why?
|
| Eukaryota | 1 | 2013 | 31 | 0.480 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2012 | 12 | 0.470 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 68 | 0.470 |
Why?
|
| Oocytes | 1 | 2013 | 176 | 0.450 |
Why?
|
| RNA Interference | 4 | 2016 | 580 | 0.440 |
Why?
|
| Germ Cells | 4 | 2021 | 95 | 0.440 |
Why?
|
| Staining and Labeling | 1 | 2012 | 123 | 0.420 |
Why?
|
| Oligonucleotide Probes | 1 | 2010 | 43 | 0.410 |
Why?
|
| Nucleotides | 2 | 2001 | 37 | 0.410 |
Why?
|
| Fluorescent Dyes | 2 | 2017 | 186 | 0.400 |
Why?
|
| Nucleic Acids | 1 | 2010 | 41 | 0.390 |
Why?
|
| Oligonucleotides | 1 | 2012 | 180 | 0.390 |
Why?
|
| Totipotent Stem Cells | 1 | 2009 | 4 | 0.390 |
Why?
|
| Nematoda | 1 | 2010 | 26 | 0.390 |
Why?
|
| Aptamers, Nucleotide | 1 | 2009 | 19 | 0.380 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 1042 | 0.380 |
Why?
|
| Protein Structure, Tertiary | 6 | 2015 | 623 | 0.360 |
Why?
|
| Myelin Sheath | 1 | 2008 | 28 | 0.350 |
Why?
|
| DNA | 1 | 2012 | 695 | 0.320 |
Why?
|
| Fluorescence Polarization | 3 | 2014 | 30 | 0.300 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 1886 | 0.290 |
Why?
|
| Drosophila Proteins | 2 | 2014 | 665 | 0.290 |
Why?
|
| Mice | 8 | 2014 | 9096 | 0.270 |
Why?
|
| Myelin Basic Protein | 1 | 2004 | 20 | 0.270 |
Why?
|
| Zinc Fingers | 3 | 2020 | 87 | 0.250 |
Why?
|
| Cytidine | 1 | 2003 | 9 | 0.240 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 2 | 2013 | 5 | 0.230 |
Why?
|
| Structure-Activity Relationship | 3 | 2014 | 342 | 0.220 |
Why?
|
| Crystallography, X-Ray | 4 | 2015 | 389 | 0.220 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 471 | 0.220 |
Why?
|
| Exons | 2 | 2013 | 181 | 0.210 |
Why?
|
| Fertility | 1 | 2021 | 79 | 0.210 |
Why?
|
| Untranslated Regions | 2 | 2012 | 3 | 0.210 |
Why?
|
| Kinetics | 3 | 2014 | 696 | 0.210 |
Why?
|
| Brain | 1 | 2008 | 1180 | 0.200 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1249 | 0.190 |
Why?
|
| Nucleotide Mapping | 1 | 1999 | 2 | 0.190 |
Why?
|
| Hermaphroditic Organisms | 1 | 2018 | 3 | 0.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2014 | 250 | 0.180 |
Why?
|
| Models, Biological | 3 | 2010 | 1096 | 0.170 |
Why?
|
| Cytoplasm | 2 | 2017 | 257 | 0.170 |
Why?
|
| Transcription Factors | 3 | 2018 | 1356 | 0.160 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 168 | 0.160 |
Why?
|
| Consensus Sequence | 2 | 2008 | 28 | 0.160 |
Why?
|
| Mice, Quaking | 2 | 2008 | 3 | 0.160 |
Why?
|
| Body Patterning | 2 | 2008 | 76 | 0.160 |
Why?
|
| Uridine Monophosphate | 1 | 2016 | 8 | 0.150 |
Why?
|
| Fluorenes | 1 | 2016 | 11 | 0.150 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2014 | 99 | 0.150 |
Why?
|
| Benzimidazoles | 1 | 2016 | 49 | 0.150 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 74 | 0.140 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 286 | 0.140 |
Why?
|
| Models, Molecular | 5 | 2015 | 1061 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 804 | 0.140 |
Why?
|
| Substrate Specificity | 3 | 2015 | 308 | 0.140 |
Why?
|
| Polyadenylation | 1 | 2015 | 43 | 0.140 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 684 | 0.140 |
Why?
|
| Mutation | 4 | 2018 | 2190 | 0.140 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2014 | 9 | 0.130 |
Why?
|
| Allosteric Site | 1 | 2014 | 32 | 0.130 |
Why?
|
| Recombinant Proteins | 2 | 2014 | 641 | 0.130 |
Why?
|
| Cytidine Deaminase | 1 | 2015 | 84 | 0.130 |
Why?
|
| DNA, Single-Stranded | 1 | 2015 | 95 | 0.130 |
Why?
|
| Binding, Competitive | 3 | 2010 | 99 | 0.130 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 150 | 0.130 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 59 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 104 | 0.120 |
Why?
|
| RNA Isoforms | 1 | 2013 | 3 | 0.120 |
Why?
|
| Inverted Repeat Sequences | 1 | 2013 | 13 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2016 | 292 | 0.120 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 22 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 68 | 0.120 |
Why?
|
| Spliceosomes | 1 | 2013 | 38 | 0.120 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 95 | 0.110 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2012 | 11 | 0.110 |
Why?
|
| Humans | 9 | 2016 | 49664 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2011 | 16 | 0.110 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2011 | 27 | 0.110 |
Why?
|
| Computational Biology | 2 | 2010 | 295 | 0.110 |
Why?
|
| Ribonucleotides | 2 | 2002 | 13 | 0.100 |
Why?
|
| Catalysis | 2 | 2001 | 139 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 82 | 0.100 |
Why?
|
| Biolistics | 1 | 2009 | 4 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2011 | 279 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 750 | 0.100 |
Why?
|
| Dimerization | 2 | 2015 | 137 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 62 | 0.100 |
Why?
|
| Qa-SNARE Proteins | 1 | 2009 | 19 | 0.090 |
Why?
|
| DNA, Complementary | 1 | 2009 | 159 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 275 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 136 | 0.090 |
Why?
|
| Algorithms | 1 | 2014 | 883 | 0.090 |
Why?
|
| Catalytic Domain | 2 | 2001 | 163 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2011 | 364 | 0.090 |
Why?
|
| Introns | 2 | 2000 | 100 | 0.090 |
Why?
|
| Vesicular Transport Proteins | 1 | 2009 | 98 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 364 | 0.080 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2008 | 27 | 0.080 |
Why?
|
| Calorimetry | 1 | 2008 | 35 | 0.080 |
Why?
|
| Models, Genetic | 2 | 2018 | 246 | 0.080 |
Why?
|
| Cell Line | 2 | 2011 | 1919 | 0.080 |
Why?
|
| Axons | 1 | 2008 | 115 | 0.080 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2008 | 80 | 0.080 |
Why?
|
| Tristetraprolin | 1 | 2007 | 5 | 0.080 |
Why?
|
| Rats | 1 | 2011 | 1676 | 0.080 |
Why?
|
| Ribonucleoproteins | 1 | 2008 | 106 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 2001 | 821 | 0.070 |
Why?
|
| Genes, Insect | 1 | 2006 | 88 | 0.070 |
Why?
|
| Female | 4 | 2018 | 26336 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 408 | 0.070 |
Why?
|
| Genes, Helminth | 1 | 2003 | 51 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1500 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2017 | 790 | 0.060 |
Why?
|
| Ions | 1 | 2003 | 50 | 0.060 |
Why?
|
| RNA, Satellite | 1 | 2001 | 1 | 0.060 |
Why?
|
| Base Pairing | 1 | 2002 | 34 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 235 | 0.060 |
Why?
|
| Models, Chemical | 2 | 1999 | 127 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2002 | 125 | 0.050 |
Why?
|
| RNA, Fungal | 1 | 2001 | 39 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 951 | 0.050 |
Why?
|
| Organophosphates | 1 | 2001 | 15 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2003 | 354 | 0.050 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2000 | 2 | 0.050 |
Why?
|
| Phospholipase D | 1 | 2000 | 5 | 0.050 |
Why?
|
| Lysophospholipids | 1 | 2000 | 17 | 0.050 |
Why?
|
| Type C Phospholipases | 1 | 2000 | 33 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2008 | 2689 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2000 | 124 | 0.050 |
Why?
|
| Guanosine | 1 | 1999 | 8 | 0.050 |
Why?
|
| Phosphorus | 1 | 1999 | 17 | 0.050 |
Why?
|
| Thionucleotides | 1 | 1999 | 34 | 0.050 |
Why?
|
| Tetrahymena | 1 | 1998 | 7 | 0.050 |
Why?
|
| RNA, Protozoan | 1 | 1998 | 9 | 0.050 |
Why?
|
| Pyrimidines | 1 | 1999 | 101 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2000 | 147 | 0.040 |
Why?
|
| Zygote | 1 | 2017 | 43 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2000 | 344 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 141 | 0.040 |
Why?
|
| Xenopus | 1 | 2017 | 50 | 0.040 |
Why?
|
| Video Recording | 1 | 2017 | 101 | 0.040 |
Why?
|
| Sofosbuvir | 1 | 2016 | 14 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2017 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 256 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 103 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 234 | 0.030 |
Why?
|
| Mesoderm | 1 | 2015 | 79 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2016 | 130 | 0.030 |
Why?
|
| Zinc | 1 | 2015 | 81 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 590 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 236 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2018 | 755 | 0.030 |
Why?
|
| Male | 2 | 2018 | 23132 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2010 | 53 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 113 | 0.030 |
Why?
|
| Genome | 1 | 2013 | 228 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2010 | 66 | 0.020 |
Why?
|
| Software | 1 | 2013 | 327 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2009 | 101 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 180 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 3127 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 429 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 184 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2009 | 718 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 1312 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2013 | 646 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 517 | 0.020 |
Why?
|
| Neurospora crassa | 1 | 2001 | 4 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 2000 | 9 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 117 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 327 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 297 | 0.010 |
Why?
|